These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37897399)

  • 1. Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia.
    Imbriglio T; Alborghetti M; Bruno V; Battaglia G; Nicoletti F; Cannella M
    Schizophr Bull; 2024 Mar; 50(2):374-381. PubMed ID: 37897399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
    Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders.
    Halff EF; Rutigliano G; Garcia-Hidalgo A; Howes OD
    Trends Neurosci; 2023 Jan; 46(1):60-74. PubMed ID: 36369028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.
    Pergola G; Di Carlo P; D'Ambrosio E; Gelao B; Fazio L; Papalino M; Monda A; Scozia G; Pietrangelo B; Attrotto M; Apud JA; Chen Q; Mattay VS; Rampino A; Caforio G; Weinberger DR; Blasi G; Bertolino A
    Transl Psychiatry; 2017 Jan; 7(1):e1006. PubMed ID: 28094815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention.
    Gomes FV; Grace AA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Aggression, Reduced Self-Grooming Behavior and Altered 5-HT Regulation in the Frontal Cortex in Mice Lacking Trace Amine-Associated Receptor 1 (TAAR1).
    Zhukov IS; Karpova IV; Krotova NA; Tissen IY; Demin KA; Shabanov PD; Budygin EA; Kalueff AV; Gainetdinov RR
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice.
    Zhang Y; Li JT; Wang H; Niu WP; Zhang CC; Zhang Y; Wang XD; Si TM; Su YA
    Pharmacol Res; 2021 May; 167():105571. PubMed ID: 33753244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of SEP-363856 within TAAR1 and the 5HT
    Nair PC; Miners JO; McKinnon RA; Langmead CJ; Gregory KJ; Copolov D; Chan SKW; Bastiampillai T
    Mol Psychiatry; 2022 Jan; 27(1):88-94. PubMed ID: 34376825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.
    Revel FG; Moreau JL; Pouzet B; Mory R; Bradaia A; Buchy D; Metzler V; Chaboz S; Groebke Zbinden K; Galley G; Norcross RD; Tuerck D; Bruns A; Morairty SR; Kilduff TS; Wallace TL; Risterucci C; Wettstein JG; Hoener MC
    Mol Psychiatry; 2013 May; 18(5):543-56. PubMed ID: 22641180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data.
    Siafis S; Chiocchia V; Macleod MR; Austin C; Homiar A; Tinsdeall F; Friedrich C; Ramage FJ; Kennett J; Nomura N; Maksym O; Rutigliano G; Vano LJ; McCutcheon RA; Gilbert D; Ostinelli EG; Stansfield C; Dehdarirad H; Juma DO; Wright S; Simple O; Elugbadebo O; Tonia T; Mantas I; Howes OD; Furukawa TA; Milligan L; Moreno C; Elliott JH; Hastings J; Thomas J; Michie S; Sena ES; Seedat S; Egger M; Potts J; Cipriani A; Salanti G; Leucht S
    Wellcome Open Res; 2024; 9():182. PubMed ID: 39036710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.
    Espinoza S; Lignani G; Caffino L; Maggi S; Sukhanov I; Leo D; Mus L; Emanuele M; Ronzitti G; Harmeier A; Medrihan L; Sotnikova TD; Chieregatti E; Hoener MC; Benfenati F; Tucci V; Fumagalli F; Gainetdinov RR
    Neuropsychopharmacology; 2015 Aug; 40(9):2217-27. PubMed ID: 25749299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug Candidates.
    Zhou Z; Zhang W; Zhao F; Sun Y; Wang N; Cheng J; Zhan P; Yang F; Sun JP; Liu X; Kang D
    J Med Chem; 2024 Mar; 67(5):4234-4249. PubMed ID: 38416116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptor in medial prefrontal cortex mediates the effects of TAAR1 activation on chronic stress-induced cognitive and social deficits.
    Sun M; Zhang Y; Zhang XQ; Zhang Y; Wang XD; Li JT; Si TM; Su YA
    Neuropsychopharmacology; 2024 Jul; 49(8):1341-1351. PubMed ID: 38658737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
    Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
    J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prefrontal cortex alterations in glia gene expression in schizophrenia with and without suicide.
    Zhang L; Verwer RWH; Lucassen PJ; Huitinga I; Swaab DF
    J Psychiatr Res; 2020 Feb; 121():31-38. PubMed ID: 31739114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the effects of antipsychotic medications on schizophrenia functional analysis: a postmortem proteome study.
    Alnafisah RS; Reigle J; Eladawi MA; O'Donovan SM; Funk AJ; Meller J; Mccullumsmith RE; Shukla R
    Neuropsychopharmacology; 2022 Nov; 47(12):2033-2041. PubMed ID: 35354897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NURR1 and ERR1 Modulate the Expression of Genes of a
    Torretta S; Rampino A; Basso M; Pergola G; Di Carlo P; Shin JH; Kleinman JE; Hyde TM; Weinberger DR; Masellis R; Blasi G; Pennuto M; Bertolino A
    J Neurosci; 2020 Jan; 40(4):932-941. PubMed ID: 31811028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
    Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
    Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia.
    Ansoleaga B; Garcia-Esparcia P; Pinacho R; Haro JM; Ramos B; Ferrer I
    J Psychiatr Res; 2015 Jan; 60():109-16. PubMed ID: 25282281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
    Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
    Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.